We are excited to announce Neurolutions IpsiHand is a finalist for Product of the Year for California Life Sciences’ Pantheon Awards! We are honored to be recognized among a group of game changers who are transforming California life sciences. We need YOUR vote!...
People recovering from a stroke will soon have access to a device that can help restore hand function. The Food and Drug Administration has authorized a device called IpsiHand®, which uses signals from the uninjured side of a patient’s brain to help rewire...
In the event of a stroke, you may experience severe or complete loss of motor function on one side of the body, known as hemiplegia (1) The side of the body in which you experience hemiplegia may depend on the location of the stroke. The classic dogma is that if a...
IpsiHand handpiece uniquely leverages brain-computer interface technology for chronic stroke rehabilitation IpsiHand also has been granted U.S. FDA Breakthrough Device Designation SANTA CRUZ, Calif. and ST. LOUIS, Mo., April 26, 2021 (GLOBE NEWSWIRE) —...
Leo Petrossian is the current Chief Executive Officer of Neurolutions, Inc. He is an experienced nanotechnologist searching for challenging opportunities in biotechnology and medical device entre- and intrapreneurship. Previously he co-founded Neural Analytics and is also the CEO of Nile AI, Inc.
Dr. Petrossian earned his MBA from the UCLA Anderson School of Management in 2014 and earned his Ph.D. & MS in Biomolecular Nanotechnology & Solid-State Device Physics as an NSF IGERT fellow at Arizona State University in 2007. He also holds a double B.S. in Electrical Engineering & Biomedical Engineering from California State University, Long Beach.
